JapanStake
Pharmaceutical · Fiscal year end Mar 31

Eisai Co., Ltd.

4523

エーザイ株式会社

FIGI BBG000BG6F834523.T4523 JPCorp. no. 6010001000001

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-12

For the first half of the fiscal year to 2026-03: Revenue ¥400 billion (+3.9% YoY), Net income ¥24.6 billion (+13.5% YoY).

This periodYear on year
Revenue¥400.0bn+3.9%
Net profit to owners¥24.6bn+13.5%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4523/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2026-03-31
Revenue
¥825.4bn
Net income
¥38.6bn
ROE
4.4%
Equity ratio
62.0%
Dividend / share
¥160
Employees
10,543
Revenue · ¥bn
FY2022: ¥756.2bn 756 FY2022FY2023: ¥744.4bn 744 FY2023FY2024: ¥741.8bn 742 FY2024FY2025: ¥789.4bn 789 FY2025FY2026: ¥825.4bn 825 FY2026
Net income · ¥bn
FY2022: ¥48.0bn 48 FY2022FY2023: ¥55.4bn 55.4 FY2023FY2024: ¥42.4bn 42.4 FY2024FY2025: ¥46.4bn 46.4 FY2025FY2026: ¥38.6bn 38.6 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥825.4bn¥38.6bn¥1,449.1bn¥899.0bn4.4%¥136.78¥61.3bn
2025-03-31¥789.4bn¥46.4bn¥1,386.5bn¥841.4bn5.4%¥163.76¥30.1bn
2024-03-31¥741.8bn¥42.4bn¥1,393.8bn¥875.6bn5.1%¥147.86¥56.0bn
2023-03-31¥744.4bn¥55.4bn¥1,263.4bn¥800.0bn7.2%¥193.31−¥1.8bn
2022-03-31¥756.2bn¥48.0bn¥1,239.3bn¥748.8bn6.6%¥167.27¥117.6bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %4.421.3
Ordinary margin——
Equity ratio, %6261.6
Revenue growth0.045647.9
Net income growth-0.169624.4
Operating cash flow / assets0.042335.2
Policy-uncertainty measure0.34 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 1.4% held by other listed companies.

Results wording balance: +0.83. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥186.1bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥930m, 1.5% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4523/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Bond ratings stated in filings: R&I AA- (2026-06-04, 第8回無担保社債). One bond's rating on that date, as the company stated it; it may have changed. The agencies' opinions, not ours. /v1/companies/4523/credit-ratings
Internal control, 2026-06-12: see filing 評価手続の結果、当社の2026年3月31日現在の財務報告に係る内部統制は、有効であると判断しています。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Japan, Americas, China, EMEA, East Asia Global South, Other. /v1/companies/4523/segments
Latest voting result: 2026-06-17 · 取締役12名選任の件 · passed. /v1/companies/4523/voting

Ownership changes

All companies →

5% filings

Large shareholding reports on 4523
FiledFilerStakeChangeStated purpose
2026-07-21BlackRock Japan Co., Ltd.8.52%+0.03ptpure investment
2026-07-06Nomura Securities Co.,Ltd.7.29%+1.09pt—
2026-05-22BlackRock Japan Co., Ltd.8.49%+0.04ptpure investment
2026-04-03BlackRock Japan Co., Ltd.8.45%+0.54ptpure investment
2025-11-05BlackRock Japan Co., Ltd.7.91%+0.09ptpure investment
2025-09-19Sumitomo Mitsui Trust Asset Management Co.,Ltd.6.37%+0.86pt—
2025-09-18BlackRock Japan Co., Ltd.7.82%+0.57ptpure investment
2025-06-06Wellington Management Company LLP4.82%−1.10pt—
2025-03-06BlackRock Japan Co., Ltd.7.25%+1.08ptpure investment
2025-02-05Wellington Management Company LLP5.92%−1.08pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
8 issues
Book value
¥16.3bn
Sold in the year
¥12.4bn 5 issues
Bought in the year
¥4.0bn 2 issues
Mutual, both reports
5
Held by listed cos.
19
HoldsBook valueShares vs. prior yearMutual
MatsukiyoCocokara & Co 3088¥11.5bn-46.2%both reports
MEDIPAL HOLDINGS CORPORATION 7459¥4.0bn0.0%stated
NIHON KOHDEN CORPORATION 6849¥1.6bn—both reports
INTAGE HOLDINGS Inc. 4326¥1.0bn—both reports
Cogstate Ltd.¥1.0bn-49.3%no
LIFENET INSURANCE COMPANY 7157¥0.7bn0.0%no
NISSHIN SEIFUN GROUP INC. 2002¥0.5bn0.0%no
㈱ほくやく・竹山ホールディングス¥0.5bn0.0%stated
PRISM BioLab Co.,LTD 206A¥0.1bn0.0%no
SUZUKEN CO.,LTD. 9987¥0.0bn0.0%both reports

Held by: Tokio Marine Holdings, Inc. 8766, MatsukiyoCocokara & Co 3088, MS&AD Insurance Group Holdings, Inc. 8725, TSUMUGU Holdings, Inc. 3055, VITAL KSK HOLDINGS,INC. 3151, NIHON KOHDEN CORPORATION 6849, taisei corporation 1801, VITAL KSK HOLDINGS,INC. 3151, TAIYOKAGAKU CO.,LTD. 2902, INTAGE HOLDINGS Inc. 4326, HAKUHODO DY HOLDINGS INCORPORATED 2433, Sasatoku Printing Co., Ltd. 3958 and 9 more

Purposes, all holdings and mutual flags via /v1/companies/4523/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
日本マスタートラスト信託銀行株式会社(信託口)52,319,00018.55%
株式会社日本カストディ銀行(信託口)28,186,0009.99%
STATE STREET BANK AND TRUST COMPANY 50500114,975,0005.31%
JPモルガン証券株式会社7,535,0002.67%
日本生命保険相互会社6,500,0002.30%
ゴールドマン・サックス証券株式会社BNYM5,175,0001.83%
公益財団法人内藤記念科学振興財団4,212,0001.49%
JP MORGAN CHASE BANK 3857813,922,0001.39%
STATE STREET BANK AND TRUST COMPANY 5051032,635,0000.93%
individual holder2,620,0000.93%

U.S. funds holding 4523

SEC Form N-PORT, reports to 2026-07-31

210 U.S. funds held 34,285,497 shares worth $973.9m.

FundSharesValue% of fundAs of
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
7,339,417$220.6m0.578%2026-07-31
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
3,929,223$118.1m0.018%2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
2,584,262$65.1m0.021%2026-06-30
The Hartford International Value Fund
HARTFORD MUTUAL FUNDS, INC
1,998,881$60.1m0.370%2026-07-31
iShares Core MSCI EAFE ETF
iShares Trust
1,867,200$56.1m0.030%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4523
GET /v1/companies/4523/financials
GET /v1/companies/4523/details
GET /v1/companies/4523/segments
GET /v1/companies/4523/voting
GET /v1/companies/4523/tender-offers
GET /v1/companies/4523/indicators
GET /v1/companies/4523/earnings-releases
GET /v1/events?ticker=4523
GET /v1/companies/4523/trades         
GET /v1/companies/4523/cross-holdings 
GET /v1/companies/4523/brief          

Plans from $9 a month · Documentation